JP2023524874A5 - - Google Patents
Info
- Publication number
- JP2023524874A5 JP2023524874A5 JP2022568554A JP2022568554A JP2023524874A5 JP 2023524874 A5 JP2023524874 A5 JP 2023524874A5 JP 2022568554 A JP2022568554 A JP 2022568554A JP 2022568554 A JP2022568554 A JP 2022568554A JP 2023524874 A5 JP2023524874 A5 JP 2023524874A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- group
- nanoparticles
- composition
- nhc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20174156.8A EP3909612A1 (en) | 2020-05-12 | 2020-05-12 | Composition of nanoparticles |
| EP20174156.8 | 2020-05-12 | ||
| PCT/EP2021/062751 WO2021229015A1 (en) | 2020-05-12 | 2021-05-12 | Composition of nanoparticles |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023524874A JP2023524874A (ja) | 2023-06-13 |
| JP2023524874A5 true JP2023524874A5 (cg-RX-API-DMAC7.html) | 2024-05-22 |
Family
ID=70682623
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568723A Pending JP2023529065A (ja) | 2020-05-12 | 2021-05-12 | Ｈｐｖ由来の免疫原性フラグメントのためのの担体としてのナノ粒子の組成物 |
| JP2022568554A Pending JP2023524874A (ja) | 2020-05-12 | 2021-05-12 | ナノ粒子の組成物 |
| JP2022568724A Pending JP2023529066A (ja) | 2020-05-12 | 2021-05-12 | アジュバント／抗原の担体系としてのナノ粒子 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568723A Pending JP2023529065A (ja) | 2020-05-12 | 2021-05-12 | Ｈｐｖ由来の免疫原性フラグメントのためのの担体としてのナノ粒子の組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568724A Pending JP2023529066A (ja) | 2020-05-12 | 2021-05-12 | アジュバント／抗原の担体系としてのナノ粒子 |
Country Status (4)
| Country | Link |
|---|---|
| US (4) | US20240197909A1 (cg-RX-API-DMAC7.html) |
| EP (6) | EP3909612A1 (cg-RX-API-DMAC7.html) |
| JP (3) | JP2023529065A (cg-RX-API-DMAC7.html) |
| WO (3) | WO2021229015A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3909612A1 (en) * | 2020-05-12 | 2021-11-17 | Life Science Inkubator Betriebs GmbH & Co. KG | Composition of nanoparticles |
| CN113274492B (zh) * | 2021-05-21 | 2022-06-17 | 大连理工大学 | 一种基于羟基氧化铝纳米羧基改性的复合疫苗佐剂的制备方法 |
| EP4547258A4 (en) * | 2022-06-28 | 2026-08-05 | Transcode Therapeutics Inc | Matrix-Directed Rig-I Agonitor Nanoparticles and Precursor Compositions and Their Uses in Cancer Therapy |
| EP4551242A4 (en) * | 2022-07-08 | 2026-06-24 | Mark C Poznansky | VACCINE CONTAINING A PROTEIN IMMUNE ADJUVANT |
| EP4673170A1 (en) * | 2023-03-02 | 2026-01-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | A therapeutic hpv vaccine based on validated target epitopes |
| CN120857941A (zh) * | 2023-03-02 | 2025-10-28 | 德国癌症研究公共权益基金会 | 经验证的hpv16衍生的刺激肽 |
| EP4673166A1 (en) * | 2023-03-02 | 2026-01-07 | Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts | Therapeutic hpv vaccines based on validated target epitopes |
Family Cites Families (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3616133A1 (de) | 1985-09-25 | 1987-11-19 | Merck Patent Gmbh | Kugelfoermige sio(pfeil abwaerts)2(pfeil abwaerts)-partikel |
| US6419931B1 (en) * | 1991-08-26 | 2002-07-16 | Epimmune Inc. | Compositions and methods for eliciting CTL immunity |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| ES2148259T3 (es) | 1993-09-22 | 2000-10-16 | Hoechst Ag | Pro-profarmacos, su produccion y uso. |
| US6429199B1 (en) | 1994-07-15 | 2002-08-06 | University Of Iowa Research Foundation | Immunostimulatory nucleic acid molecules for activating dendritic cells |
| US6180095B1 (en) | 1997-12-17 | 2001-01-30 | Enzon, Inc. | Polymeric prodrugs of amino- and hydroxyl-containing bioactive agents |
| DE19912502A1 (de) * | 1999-03-19 | 2000-09-21 | Inst Neue Mat Gemein Gmbh | Nanoskalige Teilchen, Komplexe mit Polynukleotiden und deren Verwendung |
| IL148844A0 (en) | 1999-09-27 | 2002-09-12 | Coley Pharm Group Inc | Methods related to immunostimulatory nucleic acid-induced interferon |
| KR100919266B1 (ko) * | 2000-06-26 | 2009-09-30 | 엔벤타 바이오파마슈티컬스 코포레이션 | 인간 파필로마 바이러스 치료법 |
| DE102004011110A1 (de) | 2004-03-08 | 2005-09-22 | Merck Patent Gmbh | Verfahren zur Herstellung monodisperser SiO2-Partikel |
| US20060088599A1 (en) * | 2004-08-02 | 2006-04-27 | Prasad Paras N | Amino functionalized ORMOSIL nanoparticles as delivery vehicles |
| ES2625905T3 (es) | 2004-10-01 | 2017-07-20 | Midatech Ltd. | Nanopartículas que comprenden antígenos y adyuvantes capaces de estimular linfocitos T cooperadores |
| WO2006063252A2 (en) | 2004-12-09 | 2006-06-15 | Alnylam Pharmaceuticals, Inc. | Compositions and methods for inducing an immune response in a mammal and methods of avoiding an immune response to oligonucleotide agents such as short interfering rnas |
| CN101160048A (zh) * | 2004-12-30 | 2008-04-09 | 哈达斯特医学研究服务与开发有限公司 | 形成非析出性持续抗微生物聚合组合物的抗微生物纳米颗粒添加剂 |
| WO2007031734A1 (en) | 2005-09-14 | 2007-03-22 | Ucb Pharma S.A. | Comb polymers |
| EP1764107A1 (en) | 2005-09-14 | 2007-03-21 | Gunther Hartmann | Compositions comprising immunostimulatory RNA oligonucleotides and methods for producing said RNA oligonucleotides |
| JP2010500011A (ja) | 2006-08-08 | 2010-01-07 | ガンサー ハートマン | ５’リン酸オリゴヌクレオチドの構造および使用 |
| FR2908305B1 (fr) | 2006-11-10 | 2009-02-27 | Oreal | Procede de deformation permanente des fibres keratiniques comprenant une etape d'application d'une composition de rincage intermediaire comprenant un sel de cation metallique monovalent ou un sel d'ammonium et un acide organique |
| JP5448369B2 (ja) * | 2008-05-15 | 2014-03-19 | 古河電気工業株式会社 | 粒子表面にアミノ基を有するシリカ粒子の製造方法、粒子表面にアミノ基を有するシリカ粒子、及びそれを用いた複合粒子 |
| DK2518150T3 (en) | 2008-05-21 | 2015-12-07 | Univ Bonn | 5'Trip phosphate triphosphate oligonucleotide and uses thereof |
| US9738680B2 (en) | 2008-05-21 | 2017-08-22 | Rheinische Friedrich-Wilhelms-Universität Bonn | 5′ triphosphate oligonucleotide with blunt end and uses thereof |
| DE102008033175A1 (de) | 2008-07-15 | 2010-01-21 | Merck Patent Gmbh | Siliciumdioxid-Nanopartikel und deren Verwendung zur Vakzinierung |
| EP3263707A1 (en) | 2009-03-17 | 2018-01-03 | Rheinische Friedrich-Wilhelms-Universität Bonn | Tlr8 ligand and uses thereof |
| ES2366841B1 (es) * | 2010-04-06 | 2013-01-24 | Consejo Superior De Investigaciones Cientificas (Csic) (45%) | Nanoparticulas de silice para difusion intracelular de agentes bioactivos poco solubles |
| CN103002922B (zh) | 2010-06-10 | 2015-11-25 | Mida科技有限公司 | 携带肽的纳米颗粒 |
| DE102011018499A1 (de) * | 2011-04-23 | 2012-10-25 | Emc Microcollections Gmbh | Topische Nanopartikel-Vakzine zur Immunstimulation der dendritischen Zellen in der Haut |
| BR112014005362A2 (pt) | 2011-09-07 | 2017-06-13 | Immunotope Inc | vacinas de tumor com nanopartículas |
| JP6077544B2 (ja) | 2011-09-07 | 2017-02-08 | ミダテック リミテッド | ナノ粒子−ペプチド組成物 |
| EP2883550A1 (en) | 2013-12-12 | 2015-06-17 | Deutsches Krebsforschungszentrum Stiftung des Öffentlichen Rechts | Novel promiscuous HPV16-derived T helper epitopes for immunotherapy |
| MA39909B1 (fr) | 2014-04-25 | 2019-05-31 | Pf Medicament | Conjugué anticorps de l'igf-1r-médicament et son utilisation pour le traitement du cancer |
| WO2016013751A1 (ko) * | 2014-07-22 | 2016-01-28 | 주식회사 레모넥스 | 생리활성 물질 또는 단백질 전달용 조성물 및 이의 용도 |
| US20160090603A1 (en) * | 2014-09-30 | 2016-03-31 | Sandia Corporation | Delivery platforms for the domestication of algae and plants |
| EP3370741B1 (en) * | 2015-11-04 | 2025-10-08 | The Trustees of the University of Pennsylvania | Methods and compositions for gene editing in hematopoietic stem cells |
| PT3319587T (pt) * | 2015-11-17 | 2019-11-20 | Bioncotech Therapeutics S L | Nova composição farmacêutica que compreende partículas compreendendo um complexo de um polirribonuleótido de cadeia dupla e uma polialquilenoimina |
| EP3471778A4 (en) * | 2016-06-20 | 2020-02-19 | The Regents of The University of Michigan | COMPOSITIONS AND METHOD FOR DELIVERING BIOMACROMOLECOLIC ACTIVE SUBSTANCES |
| EP3535284B1 (en) | 2016-11-07 | 2021-04-21 | The United States of America as represented by The Secretary Department of Health and Human Services | Development of agonist epitopes of the human papillomavirus |
| WO2019028387A1 (en) * | 2017-08-03 | 2019-02-07 | Rita Elena Serda | LIPOSOMAL COATED NANOPARTICLES FOR IMMUNOTHERAPY APPLICATIONS |
| GB201718817D0 (en) * | 2017-11-14 | 2017-12-27 | N4 Pharma Uk Ltd | Particulate material production process |
| US20210196838A1 (en) * | 2018-08-24 | 2021-07-01 | Mirexus Biotechnologies Inc. | Compounds and compositions for potentiation of tlr agonists |
| EP3909612A1 (en) * | 2020-05-12 | 2021-11-17 | Life Science Inkubator Betriebs GmbH & Co. KG | Composition of nanoparticles |
-
2020
- 2020-05-12 EP EP20174156.8A patent/EP3909612A1/en not_active Withdrawn
- 2020-09-14 EP EP20196027.5A patent/EP3909614A1/en not_active Withdrawn
- 2020-09-14 EP EP20196024.2A patent/EP3909613A1/en not_active Withdrawn
-
2021
- 2021-05-12 US US17/998,318 patent/US20240197909A1/en not_active Abandoned
- 2021-05-12 WO PCT/EP2021/062751 patent/WO2021229015A1/en not_active Ceased
- 2021-05-12 WO PCT/EP2021/062759 patent/WO2021229020A1/en not_active Ceased
- 2021-05-12 WO PCT/EP2021/062748 patent/WO2021229014A1/en not_active Ceased
- 2021-05-12 EP EP21724703.0A patent/EP4149561A1/en active Pending
- 2021-05-12 JP JP2022568723A patent/JP2023529065A/ja active Pending
- 2021-05-12 US US17/924,258 patent/US20230181727A1/en active Pending
- 2021-05-12 EP EP21724702.2A patent/EP4149560A1/en active Pending
- 2021-05-12 US US17/924,193 patent/US20230272014A1/en active Pending
- 2021-05-12 JP JP2022568554A patent/JP2023524874A/ja active Pending
- 2021-05-12 EP EP21725179.2A patent/EP4149562A1/en active Pending
- 2021-05-12 JP JP2022568724A patent/JP2023529066A/ja active Pending
-
2025
- 2025-06-27 US US19/252,301 patent/US20260000754A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023529066A5 (cg-RX-API-DMAC7.html) | ||
| JP2690276B2 (ja) | 静電結合型高分子ミセル薬物担体とその薬剤 | |
| JP2023529065A5 (cg-RX-API-DMAC7.html) | ||
| Besenius | Controlling supramolecular polymerization through multicomponent self‐assembly | |
| Schlaad | Solution properties of polypeptide-based copolymers | |
| Frisch et al. | pH‐switchable self‐assembled materials | |
| Habraken et al. | Block Copolypeptides Prepared by N‐Carboxyanhydride Ring‐Opening Polymerization | |
| US8318205B2 (en) | Polyethylene glycol/polycation block copolymers | |
| CN100415296C (zh) | 含包合配合物的组合物 | |
| Petersen et al. | Star-Shaped Poly (ethylene glycol)-b lock-polyethylenimine Copolymers Enhance DNA Condensation of Low Molecular Weight Polyethylenimines | |
| Rodríguez-Hernández et al. | Highly branched poly (L-lysine) | |
| KR101617790B1 (ko) | 치료, 진단과 실험적 혼합물들의 운반을 위한 공학적으로 가변된 나노입자 및 치료용 관련 조성물 | |
| US7270832B2 (en) | Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation | |
| US6716450B1 (en) | Enhancing protein activity through nanoencapsulation | |
| CN108210932B (zh) | 一种电荷驱动自组装壳聚糖基载药纳米粒子的制备方法 | |
| JP2012532185A5 (cg-RX-API-DMAC7.html) | ||
| JP2004513981A5 (cg-RX-API-DMAC7.html) | ||
| JP2008539297A (ja) | グラフト化ポリリジンデンドリマーの製造方法 | |
| JP2007532666A5 (cg-RX-API-DMAC7.html) | ||
| Jin et al. | Zwitterionicphosphorylcholine as a better ligand for stabilizing large biocompatible gold nanoparticles | |
| US20100086601A1 (en) | Modified Calcium Phosphate Nanoparticle Formation | |
| US7375096B1 (en) | Method of preparing a supramolecular complex containing a therapeutic agent and a multi-dimensional polymer network | |
| JP2009274923A (ja) | 粒子表面にアミノ基を有するシリカ粒子の製造方法、粒子表面にアミノ基を有するシリカ粒子、及びそれを用いた複合粒子 | |
| Conticello et al. | Biomaterials made from coiled-coil peptides | |
| Shcharbin et al. | The effect of PAMAM dendrimers on human and bovine serum albumin at different pH and NaCl concentrations |